April 2008

Global Clinical Connections

March 31, 2008

Building Relationship Bridges Forming a winning CRO/sponsor partnership requires trust, communication, and understand ing the expectations and needs of the other party. Using advanced technology for communi cations, taking ownership, and getting to know your partner can ensure these elements are front and center of the relationship. GUTHRIE. XCELIENCE. Probably the single most important element […]

Last Word

March 29, 2008

James King,M.D.,FAAFP,was named Presidentelect of the American Academy of Family Physicians (AAFP) in September 2006.Previously,he served three years as a director on the AAFP board.He also serves as volunteer faculty at the University of Tennessee Center for Health Sciences, is on the medical staff of the McNairy Regional Hospital in Selmer, and is Medical Director […]

Talent Pool

March 29, 2008

previously served as VP, pharmaceutical sci ences quality. She earned a B.S. in chemistry and pharmacology and a Ph.D. in organic chemistry from the University of Liverpool in the United Kingdom. Martin Huber, M.D., SPRI’s VP, global pharmacovigilance, has been named to the additional post of deputy chief medical officer. Dr. Huber holds a B.S. […]

On the Calendar

March 29, 2008

Managing MultiJurisdictional Legal and Regulatory Risks in Clinical Trials Renaissance Brussels Hotel,Brussels,Belgium For more information, contact Cordelia Ekeocha,C5,at 442078786929, email c.ekeocha@c5online.com, or visit c5online.com. April 16–17 Pharma Marketing Research Essentials Seminar Sofitel Hotel,Philadelphia For more information, contact Stephanie Houser,TVG Marketing Research & Consulting, at 2152935412, shouser@tvginc.com,or visit tvginc.com. April 1618 The American Medical Association 28th […]

E-Media

March 29, 2008

NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES Clinical Ink has introduced clinicalink.com, a Website that provides corporate information and detailed explanations of the Clinical Ink eSource solution for the electronic capture and storage of data during clinical trials. The company also has announced plans to release in June version 1.0 of its eSource solution. Clinical Ink’s […]

What’s New

March 29, 2008

NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Publicis Selling Solutions Group has created a new divi sion, Publicis Clinical Health Partners, focused on providing integrated behaviorally based education programs for patients and healthcare professionals to optimize patient compliance and treatment outcomes. Publicis Clinical Health Partners leverages the science of behavior change through its proprietary Behavioral Wellness […]

PharmaTrax

March 29, 2008

GOLD STANDARD IN ASTHMA TREATMENT is Expected to Emerge A report by Decision Resources projects that for moterol/mometasone, an asthma therapy codevel oped by ScheringPlough and Novartis, will be approved in 2009 and become the clinical gold standard for treating asthma by 2011 because of its competitive advantages in delivery over AstraZeneca’s Symbicort. Because of […]

PharmaOutlet

March 29, 2008

It’s time to take a fresh look at a big problem — physician access. In a 2008 Arista survey of pharmaceutical managers, almost 90% reported a decrease in face to face physician access over the past five years. What was surprising was the magnitude of the prob lem; pharmaceutical managers ranked physician access as their […]

Competitive Counter-Strike

March 29, 2008

In December 1999, ParkeDavis (now Pfizer) launched Lipitor, a very potent LDL cholesterollowering agent. Despite being the fifth statin to enter the U.S. market, Pfizer overwhelmed the competition and soon made Lipitor the topselling cholesterol and pharmaceutical product in the world. By 2002, AstraZeneca was preparing to launch Crestor, a new statin with even greater […]

Janet Greeson — A Good Samaritan

March 29, 2008

company had come about from consulting with a doctor who asked her to write about an HIV drug, SP01A, one of the candidates in Samaritan’s pipeline. “I became so interested in the drug, that eventually I found myself pretty much running Steroidogenesis,” she says. The first thing she did upon taking the helm, was to […]

25 Years of the Orphan Drug Act

March 27, 2008

Synthetic drugs accounted for 62% of total orphan drug approvals, and synthetic polypep tides and hormones together accounted for 6%. Among biologics, growth hormones and growth factors together have the largest num ber of approvals at 8% of the total. Market approvals received for plasma products BY CYNTHIA BORDA Cot, M.D., MPH, director of the […]

Licensed to Sell

March 27, 2008

A NEW LEGISLATION PROPOSES THAT SALES REPS OBTAIN LICENSES BEFORE THEY CAN MEET WITH PHYSICIANS. The law currently may cause ripples only in Washington,D.C.,but some experts believe its implications will be far reaching. BY ROBIN ROBINSON 0408 Layout PROOFS 3/25/08 11:45 AM Page 58 59 PharmaVOICE Ap r i l 2 008 SALES REP legislation […]

The Softer Side of R&D

March 27, 2008

Industry experts say the technical competencies of drug development have to be combined with the softer skills of change management and leadership ability. R&D leaders will have to work in global teams to manage the output from their partners. This will require highly trained technical specialists who have strong interpersonal and communications skills. Working in […]

Agency Client Services

March 27, 2008

A SHIFTING LANDSCAPE We asked our agency executives to evaluate what they believe have been the biggest shifts in client service in the past five years. We also asked them to project what they believe the client service role will encompass in the next fiveyears. HOWDOYOUMANAGECLIENTCHALLENGES? DUNN. VOX MEDICA. Time is, and always has been, […]

Proof of Concept

March 27, 2008

BENEFITS OF EXPLORATORY INDS In a guidance released in January 2006, the FDA laid out specific approaches for researchers George Mills, M.D., VP, medical imaging consulting, for Perceptive Informatics at Parexel International, agrees that an exploratory IND is an avenue to evaluate the preclinical assessments for investigational drugs and biologics in human subjects. These confirmatory […]

UpFront

March 27, 2008

Milestones 20 YEARS OF DISCOVERY Pharmaceutical Research and Manufacturers of America (PhRMA) has marked the 20th anniversary of the Discoverers Award, the highest honor given by PhRMA to scientists who helped discover breakthrough medicines for patients suffering from disease. PhRMA presented the Discoverers Award to three then SmithKline Beecham — a GlaxoSmithKline heritage company — […]

Raise Your Voice — Letters

March 27, 2008

A Missing Link I just finished reading the March article, “Strengthening the Clinical Recruitment Chain,” and it seems to me that you forgot a crucial first step in the process you describe. This would be the establishment of a sound protocol that makes scientific sense and benefits the subject. It’s a lot easier to convince […]

Letter from the Editor

March 27, 2008

Bogey and Bacall, Rogers and Hammerstein,Ben & Jerry,or closer to home John K. Smith, Thomas Beecham, and Mahlon Kline — great partners who made for great partnerships. In developing this issue, an inadvertent theme developed, one centered around the concept of partner ships. What makes them work? What are the critical elements for success? What […]

FEEDBACK